Sort   by:  
 Page size 
To capture the changes in the lysosomal proteome upon TRPML1 activation, achieved using a small molecule agonist MLSA5, human cancer cells, with or without gene-editing, stably expressing TMEM192-mRFP-3xHA (Lyso-IP), were treated with MLSA5 and Lyso-IP samples were prepared and processed for TMT-MS ...
ORGANISM(S): Homo sapiens (Human) 
2025-04-22 | PXD054968 | Pride
Characterization of methionine dependence in melanoma cells [HumanMethylationEPIC]
Characterization of methionine dependence in melanoma cells [RNA-seq]
Sort   by:  
 Page size